miRNAs as biomarkers of neurodegenerative disorders

被引：60

作者：

Viswambharan, Vijitha ^{[1
]}

Thanseem, Ismail ^{[1
]}

Vasu, Mahesh M. ^{[2
]}

Poovathinal, Suresh A. ^{[3
]}

Anitha, Ayyappan ^{[1
]}

机构：

[1] Inst Communicat & Cognit Neurosci ICCONS, Dept Neurogenet, Palakkad 679523, Kerala, India

[2] Hamamatsu Univ, Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan

[3] Inst Communicat & Cognit Neurosci ICCONS, Dept Neurol, Palakkad 679523, Kerala, India

来源：

BIOMARKERS IN MEDICINE | 2017年 / 11卷 / 02期

关键词：

Alzheimer's disease; amyotrophic lateral sclerosis; Friedreich's ataxia; Huntington's disease; miRNA; multiple sclerosis; Parkinson's disease; prion disease; spinal muscular atrophy; spinocerebellar ataxia; MULTIPLE-SCLEROSIS PATIENTS; MICRORNA EXPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CIRCULATING MICRORNAS; FRIEDREICH ATAXIA; GENETIC-ANALYSIS; BARRIER FUNCTION; RNA EXPRESSION; UP-REGULATION;

D O I：

10.2217/bmm-2016-0242

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Neurodegenerative diseases (NDDs) are the result of progressive deterioration of neurons, ultimately leading to disabilities. There is no effective cure for NDDs at present; ongoing therapies are mainly aimed at treating the most bothersome symptoms. Since early treatment is crucial in NDDs, there is an urgent need for specific and sensitive biomarkers that can aid in early diagnosis of these disorders. Recently, altered expression of miRNAs has been implicated in several neurological disorders, including NDDs. miRNA expression has been extensively investigated in the cells, tissues and body fluids of patients with different types of NDDs. The aim of this review is to provide a comprehensive overview of miRNAs as biomarkers and therapeutic targets for NDDs.

引用

页码：151 / 167

页数：17

共 50 条

[1] Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Grasso, Margherita
Piscopo, Paola
Confaloni, Annamaria
Denti, Michela A.
MOLECULES, 2014, 19 (05): : 6891 - 6910
[2] Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
Sivalingam, Azhagu Madhavan
Sureshkumar, Darshitha D.
MOLECULAR NEUROBIOLOGY, 2025,
[3] Biomarkers of neurodegenerative disorders
Land, JM
BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, 2002, : 391 - 397
[4] A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders
Perdoncin, Maddie
Konrad, Alec
Wyner, Joshua R.
Lohana, Samir
Pillai, Sneha S.
Pereira, Duane G.
Lakhani, Hari Vishal
Sodhi, Komal
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
[5] Early Biomarkers for Neurodegenerative Disorders
Lee, Chau-Shoun
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2016, 10 (04) : 189 - 189
[6] MRI BIOMARKERS IN NEURODEGENERATIVE DISORDERS
Schott, Jonathan M.
2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2012, : 912 - 912
[7] miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy
Karnati, Hanuma Kumar
Panigrahi, Manas Kumar
Gutti, Ravi Kumar
Greig, Nigel H.
Tamargo, Ian A.
JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (03) : 563 - 580
[8] Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Gentile, Giulia
Morello, Giovanna
La Cognata, Valentina
Guarnaccia, Maria
Conforti, Francesca Luisa
Cavallaro, Sebastiano
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
[9] Circulating miRNAs as biomarkers for endocrine disorders
H. Butz
N. Kinga
K. Racz
A. Patocs
Journal of Endocrinological Investigation, 2016, 39 : 1 - 10
[10] Circulating miRNAs as biomarkers for endocrine disorders
Butz, H.
Kinga, N.
Racz, K.
Patocs, A.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (01) : 1 - 10

← 1 2 3 4 5 →